Northern Trust Corp Haemonetics Corp Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Haemonetics Corp stock. As of the latest transaction made, Northern Trust Corp holds 584,413 shares of HAE stock, worth $44.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
584,413
Previous 585,706 0.22%
Holding current value
$44.8 Million
Previous $48.5 Million 3.07%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$72.45 - $91.58 $93,677 - $118,412
-1,293 Reduced 0.22%
584,413 $47 Million
Q2 2024

Aug 14, 2024
BUY
$81.24 - $97.37 $836,447 - $1 Million
10,296 Added 1.79%
585,706 $48.5 Million
Q1 2024

May 14, 2024
SELL
$71.24 - $85.35 $3.78 Million - $4.53 Million
-53,102 Reduced 8.45%
575,410 $49.1 Million
Q4 2023

Feb 13, 2024
SELL
$80.59 - $92.61 $898,739 - $1.03 Million
-11,152 Reduced 1.74%
628,512 $53.7 Million
Q3 2023

Nov 13, 2023
SELL
$82.56 - $93.49 $782,173 - $885,724
-9,474 Reduced 1.46%
639,664 $57.3 Million
Q2 2023

Aug 11, 2023
BUY
$80.84 - $89.45 $55,860 - $61,809
691 Added 0.11%
649,138 $55.3 Million
Q1 2023

May 15, 2023
BUY
$72.75 - $90.6 $172,199 - $214,450
2,367 Added 0.37%
648,447 $53.7 Million
Q4 2022

Feb 13, 2023
SELL
$73.85 - $86.14 $337,937 - $394,176
-4,576 Reduced 0.7%
646,080 $50.8 Million
Q3 2022

Nov 14, 2022
SELL
$63.3 - $78.66 $729,469 - $906,477
-11,524 Reduced 1.74%
650,656 $48.2 Million
Q2 2022

Aug 12, 2022
SELL
$49.27 - $66.08 $798,272 - $1.07 Million
-16,202 Reduced 2.39%
662,180 $43.2 Million
Q1 2022

May 13, 2022
SELL
$43.77 - $63.22 $1.26 Million - $1.81 Million
-28,674 Reduced 4.06%
678,382 $42.9 Million
Q4 2021

Feb 08, 2022
SELL
$49.55 - $74.59 $309,687 - $466,187
-6,250 Reduced 0.88%
707,056 $37.5 Million
Q3 2021

Nov 15, 2021
BUY
$57.6 - $70.59 $44,582 - $54,636
774 Added 0.11%
713,306 $50.4 Million
Q2 2021

Aug 13, 2021
BUY
$51.81 - $118.56 $14.2 Million - $32.5 Million
274,322 Added 62.6%
712,532 $47.5 Million
Q1 2021

May 12, 2021
BUY
$111.01 - $139.48 $3.5 Million - $4.4 Million
31,518 Added 7.75%
438,210 $48.6 Million
Q4 2020

Feb 11, 2021
SELL
$88.75 - $119.95 $280,361 - $378,922
-3,159 Reduced 0.77%
406,692 $48.3 Million
Q3 2020

Nov 16, 2020
SELL
$75.65 - $93.58 $1.05 Million - $1.3 Million
-13,895 Reduced 3.28%
409,851 $35.8 Million
Q2 2020

Aug 14, 2020
SELL
$84.96 - $118.91 $34.1 Million - $47.7 Million
-401,532 Reduced 48.65%
423,746 $38 Million
Q1 2020

May 14, 2020
SELL
$74.34 - $121.82 $98,277 - $161,046
-1,322 Reduced 0.16%
825,278 $82.2 Million
Q4 2019

Feb 14, 2020
SELL
$114.37 - $129.46 $1.83 Million - $2.07 Million
-16,011 Reduced 1.9%
826,600 $95 Million
Q3 2019

Nov 13, 2019
BUY
$117.16 - $138.52 $822,931 - $972,964
7,024 Added 0.84%
842,611 $106 Million
Q2 2019

Aug 13, 2019
BUY
$81.74 - $120.34 $364,396 - $536,475
4,458 Added 0.54%
835,587 $101 Million
Q1 2019

May 13, 2019
BUY
$83.25 - $102.12 $312,437 - $383,256
3,753 Added 0.45%
831,129 $72.7 Million
Q4 2018

Feb 12, 2019
SELL
$90.66 - $116.63 $894,451 - $1.15 Million
-9,866 Reduced 1.18%
827,376 $82.8 Million
Q3 2018

Nov 14, 2018
SELL
$89.96 - $114.58 $205,378 - $261,586
-2,283 Reduced 0.27%
837,242 $95.9 Million
Q2 2018

Sep 18, 2018
SELL
$71.53 - $95.75 $284,403 - $380,702
-3,976 Reduced 0.47%
839,525 $75.3 Million
Q2 2018

Aug 14, 2018
BUY
$71.53 - $95.75 $11.4 Million - $15.3 Million
159,430 Added 23.31%
843,501 $75.6 Million
Q1 2018

May 09, 2018
BUY
$60.72 - $74.41 $447,627 - $548,550
7,372 Added 1.09%
684,071 $50 Million
Q4 2017

Feb 14, 2018
SELL
$44.96 - $58.99 $250,472 - $328,633
-5,571 Reduced 0.82%
676,699 $39.3 Million
Q3 2017

Nov 13, 2017
BUY
$40.38 - $44.87 $27.6 Million - $30.6 Million
682,270
682,270 $30.6 Million

Others Institutions Holding HAE

# of Institutions
332
Shares Held
53.8M
Call Options Held
689K
Put Options Held
345K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.93B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email